echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Express AI helps develop innovative protein degraders, and Boehringer Ingelheim reaches R&D cooperation

    Express AI helps develop innovative protein degraders, and Boehringer Ingelheim reaches R&D cooperation

    • Last Update: 2022-06-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, VantAI and Boehringer Ingelheim jointly announced that they have entered into an early drug discovery research collaboration focused on the discovery of innovative degraders that degrade traditional "undruggable" targets


    VantAI, a subsidiary of Roivant Sciences, uses machine learning to design and optimize induced proximity drugs


    The company's evolutionary scoring system draws on naturally occurring protein-protein interaction interfaces, allowing generative models to design molecular glues with smaller molecular weights to form highly cooperative ternary complexes


    "We are very excited to collaborate with Boehringer Ingelheim in the field of induced proximity, specifically targeting 'non-druggable' disease targets


    Boehringer Ingelheim will provide VantAI with undisclosed upfront payments and preclinical, clinical and commercial milestone payments


    References:

    References:

    [1] VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders.


    [1] VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders.
    Retrieved April 21, 2022, from https:// -Forms-Research-Collaboration-with-Boehringer-Ingelheim-to-Identify-Novel-Protein-Degraders.
    html
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.